These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34468739)

  • 1. Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
    Prifti E; Fall A; Davogustto G; Pulini A; Denjoy I; Funck-Brentano C; Khan Y; Durand-Salmon A; Badilini F; Wells QS; Leenhardt A; Zucker JD; Roden DM; Extramiana F; Salem JE
    Eur Heart J; 2021 Oct; 42(38):3948-3961. PubMed ID: 34468739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology.
    Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C
    Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the QT interval in patients with drug-induced QT prolongation and torsades de pointes.
    Krisai P; Vlachos K; Ramirez FD; Nakatani Y; Nakashima T; Takagi T; Kamakura T; Surget E; André C; Cheniti G; Welte N; Chauvel R; Tixier R; Duchateau J; Pambrun T; Derval N; Hocini M; Jaïs P; Haïssaguerre M; Sacher F
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2696-2701. PubMed ID: 32700358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Best ECG Lead for Predicting the Risk of Drug-Induced Torsade De Pointes Using Corrected QT Interval: A Comparative Prognostic Study.
    Raicharoen T; Vassasunthorn S; Othong R
    Arch Acad Emerg Med; 2025; 13(1):e5. PubMed ID: 39318863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT variability during initial exposure to sotalol: experience based on a large electronic medical record.
    Weeke P; Delaney J; Mosley JD; Wells Q; Van Driest S; Norris K; Kucera G; Stubblefield T; Roden DM
    Europace; 2013 Dec; 15(12):1791-7. PubMed ID: 23787903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Learning-Augmented ECG Analysis for Screening and Genotype Prediction of Congenital Long QT Syndrome.
    Jiang R; Cheung CC; Garcia-Montero M; Davies B; Cao J; Redfearn D; Laksman ZM; Grondin S; Atallah J; Escudero CA; Cadrin-Tourigny J; Sanatani S; Steinberg C; Joza J; Avram R; Tadros R; Krahn AD
    JAMA Cardiol; 2024 Apr; 9(4):377-384. PubMed ID: 38446445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram.
    Bos JM; Attia ZI; Albert DE; Noseworthy PA; Friedman PA; Ackerman MJ
    JAMA Cardiol; 2021 May; 6(5):532-538. PubMed ID: 33566059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTNet: Predicting Drug-Induced QT Prolongation With Artificial Intelligence-Enabled Electrocardiograms.
    Zhang H; Tarabanis C; Jethani N; Goldstein M; Smith S; Chinitz L; Ranganath R; Aphinyanaphongs Y; Jankelson L
    JACC Clin Electrophysiol; 2024 May; 10(5):956-966. PubMed ID: 38703162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis.
    Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA
    Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.
    Schwartz PJ; Woosley RL
    J Am Coll Cardiol; 2016 Apr; 67(13):1639-1650. PubMed ID: 27150690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.
    Sugrue A; Kremen V; Qiang B; Sheldon SH; DeSimone CV; Sapir Y; Striemer BL; Brady P; Asirvatham SJ; Ackerman MJ; Friedman P; Noseworthy PA
    Cardiovasc Drugs Ther; 2015; 29(5):433-41. PubMed ID: 26411977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality.
    Weeke PE; Kellemann JS; Jespersen CB; Theilade J; Kanters JK; Hansen MS; Christiansen M; Marstrand P; Gislason GH; Torp-Pedersen C; Bundgaard H; Jensen HK; Tfelt-Hansen J
    Eur Heart J; 2019 Oct; 40(37):3110-3117. PubMed ID: 31079148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.
    Cole JB; Lee SC; Martel ML; Smith SW; Biros MH; Miner JR
    West J Emerg Med; 2020 Jul; 21(4):728-736. PubMed ID: 32726229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.